These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26228720)

  • 1. [Conflicts of interest: should we lower our guard?].
    De Fiore L
    Recenti Prog Med; 2015 Jul; 106(7):305-7. PubMed ID: 26228720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New contract recommendations for physicians cooperating with the pharmaceutical industry? The "FS Codex" and its consequences for physicians].
    Häser I; Hofmann A
    Orthopade; 2005 Mar; 34(3):263-4, 266. PubMed ID: 16247838
    [No Abstract]   [Full Text] [Related]  

  • 3. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
    Alpert JS
    Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical practice and pharmaceutical industry: an always difficult relationship].
    Mastai R
    Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Increase in incidence of drug treatments, ethical principles and conflict of interest in cooperation with the pharmaceutical industry].
    Hebebrand J; Blanz B; Herpertz-Dahlmann B; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 May; 40(3):133-8. PubMed ID: 22774235
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conflicts of interest: an introduction to a new focus point].
    Rzany B
    J Dtsch Dermatol Ges; 2011 Apr; 9(4):267-8. PubMed ID: 21439009
    [No Abstract]   [Full Text] [Related]  

  • 8. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public disclosure of conflicts of interest: moving the policy debate forward.
    Campbell EG
    Arch Intern Med; 2010 Apr; 170(8):667. PubMed ID: 20421548
    [No Abstract]   [Full Text] [Related]  

  • 10. "Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions.
    Ladd EC; Mahoney DF; Emani S
    Am J Manag Care; 2010 Dec; 16(12):e358-62. PubMed ID: 21291293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflicts of interest with the hand surgeon's relationship with industry.
    DelSignore JL; Goodman MJ
    J Hand Surg Am; 2012 Jan; 37(1):179-83. PubMed ID: 22196298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strategies for drug promotion].
    Polonuer JL
    Medicina (B Aires); 2005; 65(4):373-6. PubMed ID: 16193722
    [No Abstract]   [Full Text] [Related]  

  • 13. Banning pens and pads misses the main point.
    Terry SF; Burke W
    Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
    [No Abstract]   [Full Text] [Related]  

  • 14. Conflict of Interest and the CREATE-X Trial in the New England Journal of Medicine.
    Ozaki A
    Sci Eng Ethics; 2018 Dec; 24(6):1809-1811. PubMed ID: 28916944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disclosure of potential conflicts of interest in dermatological guidelines in Germany - an analysis - status quo and quo vadis.
    Rosumeck S; Sporbeck B; Rzany B; Nast A
    J Dtsch Dermatol Ges; 2011 Apr; 9(4):297-304. PubMed ID: 21439013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing conflicts of interest and commitment: academic medicine and the physician's progress.
    Kachuck NJ
    J Med Ethics; 2011 Jan; 37(1):2-5. PubMed ID: 21149321
    [No Abstract]   [Full Text] [Related]  

  • 17. [The relationship between medicine and medical suppliers].
    Heerlein A
    Rev Med Chil; 2014 Mar; 142(3):361-7. PubMed ID: 25052274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unconscious conflict of interest: a Jewish perspective.
    Gold A; Appelbaum PS
    J Med Ethics; 2011 Jul; 37(7):402-5. PubMed ID: 20852304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact with pharmaceutical representatives: where does prudence lead?
    Appelbaum PS
    Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
    [No Abstract]   [Full Text] [Related]  

  • 20. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.